Patients continue with the program in 90-day increments for as long as they find it necessary and beneficial to achieving or maintaining their goal weight
GLP-1 Prescriptions and Liability Risks With new indications for GLP-1 medications in areas such as sleep apnea, substance use disorder, and chronic kidney disease, the demand for semaglutide-based treatments is expected to continue rising
Researchers have also found that GLP-1-MK-801 alters the gene expression in signaling pathways associated with both GLP-1 and MK-801, suggesting a coordinated interaction between these two receptor systems
[1] [2] These medications work through different mechanisms, but it's important to note that GLP-1 receptor agonists like Wegovy delay gastric emptying, which could theoretically affect the absorption of oral medications including levothyroxine
Even more telling is the distribution of results
Inborn Errors of Metabolism